NUVAXOVID Trademark

Trademark Overview

On Friday, July 11, 2025, a trademark application was filed for NUVAXOVID with the United States Patent and Trademark Office. The USPTO has given the NUVAXOVID trademark a serial number of 99279709. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, July 11, 2025. This trademark is owned by Novavax, Inc.. The NUVAXOVID trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Providing medical and scientific research information in the field of Covid-19 vaccines, and clinical trials and post-market trials related to Covid-19 vaccines; consulting services in the field of research and development of Covid-19 vaccines; Covid-19 vaccine research and development
nuvaxovid

General Information

Serial Number99279709
Word MarkNUVAXOVID
Filing DateFriday, July 11, 2025
Status630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status DateFriday, July 11, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesProviding medical and scientific research information in the field of Covid-19 vaccines, and clinical trials and post-market trials related to Covid-19 vaccines; consulting services in the field of research and development of Covid-19 vaccines; Covid-19 vaccine research and development

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, July 11, 2025
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNovavax, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressGaithersburg, MD 20878

Trademark Events

Event DateEvent Description
Friday, July 11, 2025APPLICATION FILING RECEIPT MAILED
Friday, July 11, 2025NEW APPLICATION ENTERED

Related Keywords

nuvaxovid covid vaccines research trials field development related vaccine consulting market